# PD-L1 Targeting Molecular Imaging of Solid Tumors

> **NCT04629326** · NA · RECRUITING · sponsor: **Peking University Cancer Hospital & Institute** · enrollment: 20 (estimated)

## Conditions studied

- Gastrointestinal Tumors

## Interventions

- **OTHER:** 68Ga-WL12 PET/CT

## Key facts

- **NCT ID:** NCT04629326
- **Lead sponsor:** Peking University Cancer Hospital & Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-07-20
- **Primary completion:** 2024-11
- **Final completion:** 2024-11
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04629326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04629326, "PD-L1 Targeting Molecular Imaging of Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04629326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*